Tissue distribution, disposition, and metabolism of cyclosporine in rats
Journal Article
·
· Drug Metab. Dispos.; (United States)
OSTI ID:6125031
Tissue distribution, disposition, and metabolism of /sup 3/H-cyclosporine were studied in rats after single and repeated oral doses of 10 and 30 mg/kg and after an iv dose of 3 mg/kg. The oral doses of 10 and 30 mg/kg were dissolved in polyethylene glycol 200/ethanol or in olive oil/Labrafil/ethanol. Absorption from both formulations was slow and incomplete, with peak /sup 3/H blood levels at 3-4 hr. Approximately 30% of the radioactive dose was absorbed, which is consistent with oral bioavailability data for cyclosporine. More than 70% of the radioactivity was excreted in feces and up to 15% in urine. Elimination via the bile accounted for 10 and 60% of the oral and iv doses, respectively. Since unchanged cyclosporine predominated in both blood and tissues at early time points, the half-lives of the distribution phases (t 1/2 alpha) of parent drug and of total radioactivity were similar. In blood, kidney, liver, and lymph nodes, t 1/2 alpha of cyclosporine ranged from 6-10 hr. Elimination of radioactivity from the systemic circulation was multiphasic, with a terminal half-life of 20-30 hr. /sup 3/H-Cyclosporine was extensively distributed throughout the body, with highest concentrations in liver, kidney, endocrine glands, and adipose tissue. The concentrations of both total radioactivity and parent drug were greater in tissues than in blood, which is consistent with the high lipid solubility of cyclosporine and some of its metabolites. Skin and adipose tissue were the main storage sites for unchanged cyclosporine. Elimination half-lives were slower for most tissues than for blood and increased with multiple dosing. The amount of unchanged drug was negligible in urine and bile.
- Research Organization:
- Sandoz Ltd., Basel, Switzerland
- OSTI ID:
- 6125031
- Journal Information:
- Drug Metab. Dispos.; (United States), Journal Name: Drug Metab. Dispos.; (United States) Vol. 15:3; ISSN DMDSA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Pharmacokinetics and metabolism of bisoprolol-/sup 14/C in three animal species and in humans
Disposition of 2-mercaptobenzimidazole in rats dosed orally or intravenously
Metabolic disposition of CI-924, a new lipid regulating agent, in laboratory animals
Journal Article
·
Tue Dec 31 23:00:00 EST 1985
· J. Cardiovasc. Pharmacol.; (United States)
·
OSTI ID:6216022
Disposition of 2-mercaptobenzimidazole in rats dosed orally or intravenously
Journal Article
·
Sat Dec 31 23:00:00 EST 1983
· J. Toxicol. Environ. Health; (United States)
·
OSTI ID:5946517
Metabolic disposition of CI-924, a new lipid regulating agent, in laboratory animals
Conference
·
Tue Mar 04 23:00:00 EST 1986
· Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)
·
OSTI ID:7034142
Related Subjects
550501* -- Metabolism-- Tracer Techniques
59 BASIC BIOLOGICAL SCIENCES
ABSORPTION
ANIMALS
BILE
BIOLOGICAL HALF-LIFE
BIOLOGICAL MATERIALS
BODY FLUIDS
DISTRIBUTION
DRUGS
IMMUNOSUPPRESSIVE DRUGS
INTESTINAL ABSORPTION
ISOTOPE APPLICATIONS
LABELLED COMPOUNDS
MAMMALS
MATERIALS
METABOLISM
ORAL ADMINISTRATION
RATS
RODENTS
TISSUE DISTRIBUTION
TRACER TECHNIQUES
TRITIUM COMPOUNDS
UPTAKE
VERTEBRATES
59 BASIC BIOLOGICAL SCIENCES
ABSORPTION
ANIMALS
BILE
BIOLOGICAL HALF-LIFE
BIOLOGICAL MATERIALS
BODY FLUIDS
DISTRIBUTION
DRUGS
IMMUNOSUPPRESSIVE DRUGS
INTESTINAL ABSORPTION
ISOTOPE APPLICATIONS
LABELLED COMPOUNDS
MAMMALS
MATERIALS
METABOLISM
ORAL ADMINISTRATION
RATS
RODENTS
TISSUE DISTRIBUTION
TRACER TECHNIQUES
TRITIUM COMPOUNDS
UPTAKE
VERTEBRATES